TY - JOUR
T1 - Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer
AU - Haddad, Robert I.
AU - Wirth, Lori
AU - Posner, Marshall R.
PY - 2003/6
Y1 - 2003/6
N2 - The role of chemotherapy for locoregionally advanced head and neck cancer continues to evolve. Chemotherapy can be given as induction therapy, concomitant with radiation or occasionally in an adjuvant form following definitive local therapy. Timing and sequence of chemotherapy varies between institutions. The recent advances in the treatment of head and neck cancer will be reviewed, with focus on the recent application of sequential chemoradiotherapy regimens, which combines high-dose induction chemotherapy with concomitant chemoradiation. Surgery is reserved for advanced nodal-stage disease and for salvage at the primary site. This novel approach has resulted in a higher rate of organ preservation and is ultimately expected to improve survival in this patient population.
AB - The role of chemotherapy for locoregionally advanced head and neck cancer continues to evolve. Chemotherapy can be given as induction therapy, concomitant with radiation or occasionally in an adjuvant form following definitive local therapy. Timing and sequence of chemotherapy varies between institutions. The recent advances in the treatment of head and neck cancer will be reviewed, with focus on the recent application of sequential chemoradiotherapy regimens, which combines high-dose induction chemotherapy with concomitant chemoradiation. Surgery is reserved for advanced nodal-stage disease and for salvage at the primary site. This novel approach has resulted in a higher rate of organ preservation and is ultimately expected to improve survival in this patient population.
KW - Concomitant chemoradiation
KW - Head and neck cancer
KW - Induction chemotherapy
KW - Sequential chemoradiation
UR - http://www.scopus.com/inward/record.url?scp=0037531704&partnerID=8YFLogxK
U2 - 10.1586/14737140.3.3.331
DO - 10.1586/14737140.3.3.331
M3 - Review article
C2 - 12820776
AN - SCOPUS:0037531704
SN - 1473-7140
VL - 3
SP - 331
EP - 338
JO - Expert Review of Anticancer Therapy
JF - Expert Review of Anticancer Therapy
IS - 3
ER -